Main menu

NEW YORK, Oct. 1 - Orchid Biosciences has said it will acquire DNA analysis company Lifecodes in a $12.6 million all-stock deal, Orchid said on Monday.

Terms of the agreement, which have been approved by both firms’ boards of directors, call for Orchid to issue roughly 6.5 million new shares of common stock in exchange for all of Lifecodes’ outstanding equity.